ERBB2 and breast cancer: Since aneuploid and/or CIN+ tumors show a poorer prognosis [8-13,33,34], the further classification of luminal A and luminal B (HER2-) subtypes may be useful for estimating the prognosis of patients with breast cancer and for clinical decision-making.